Evidence map›Paper›PMID 41862882›Full record

Observational studyBMC nephrology2026

Risk factors and outcomes of culture-negative peritonitis in peritoneal dialysis: 10 years' insight from a large center in northern China.

Xixi Zheng, Haiyun Wang, Zijuan Zhou, Ying Wang, Wei Yang, Peng Xia, Limeng Chen

Abstract readObservational Study
In one paragraph

Observational study in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xixi Zheng *Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100730, China.
Haiyun Wang *Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100730, China.
Zijuan ZhouDepartment of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100730, China.
Ying WangDepartment of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100730, China.
Wei YangDepartment of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100730, China.
Peng XiaDepartment of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100730, China. xiapeng@pumch.cn.
Limeng ChenDepartment of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100730, China. chenlimeng@pumch.cn.

Funding

Capital Exemplary Research Wards Project BCRW202001China Academy of Chinese Medical Sciences Innovation Fund for Medical Sciences (CIFMS 2024-I2M-C&T-C-003, CIFMS 2021-I2M-1-003)China Medical Board CMB-OC #24-555National High Level Hospital Clinical Research Funding 2022-PUMCH-B-019, 2022-PUMCH-D-002Peking Union Medical College Hospital Talent Cultivation Program (Category C, UBJ11228)
6 · The paper itself

Abstract

backgroundPeritoneal dialysis-associated peritonitis is the primary cause of technical failure and infection-related mortality in PD patients. Culture-negative peritonitis poses unique management challenges. The reported incidence of culture-negative peritonitis varies substantially across regions and centers, likely reflecting differences in patient characteristics, microbiological practices, and treatment protocols. In this study, we aimed to investigate the risk factors, treatment strategies, and clinical outcomes of culture-negative peritonitis in a large peritoneal dialysis center in northern China.

methodsIn this single-center retrospective cohort study, we included consecutive peritonitis episodes from January 2013 to December 2023. We assessed patient demographics, medical history, peritonitis presentation, antibiotic use, and treatment pathways. The primary outcomes were culture-negativity and outcomes of medical cure. Logistic regression was used to identify independent risk factors for culture negativity and failure to achieve a medical cure.

resultsThe overall incidence of peritonitis during the study period was 0.15 episodes per patient-year and the culture-negative peritonitis rate was 25.5%. Patients with culture-negative peritonitis were more likely to have a smoking history (P = 0.026) and to have used antibiotics before culture collection (47.6% vs. 9.2%, P < 0.0001). A higher proportion of culture-negative cases experienced a delay of over a day from hospital presentation to obtaining a culture (27.0% vs. 8.7%, P = 0.0009). Multivariate analysis revealed that only antibiotic use before culture independently predicted culture negativity (OR = 12.40, 95% CI = 3.80 to 40.20, P < 0.0001). Culture-negative peritonitis had a medical cure rate of 76.2%, similar to Gram-positive infections (76.2% vs. 67.3%, P = 0.229) and better than Gram-negative, polymicrobial, fungal, or tuberculosis-related peritonitis. In multivariate analysis, longer dialysis vintage, culture positivity, and higher post-peritonitis hsCRP levels were associated with a failure to achieve a medical cure.

conclusionCulture-negative peritonitis had favorable outcomes compared to Gram-negative and polymicrobial peritonitis. Increased patient awareness and an optimized treatment pathway can enhance a timely and standardized culture collection and reduce the culture-negative rate.

Indexed as

Anti-Bacterial AgentsPeritoneal DialysisPeritonitisSmokingAdultAgedChinaCoinfectionFemaleGram-Negative Bacterial InfectionsGram-Positive Bacterial InfectionsHumansIncidenceMaleMiddle AgedRetrospective StudiesAnti-Bacterial AgentsCulture-negative peritonitisPeritoneal dialysis-related peritonitis

Identifiers

PMID41862882
PMCPMC13126694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.